Thursday, November 21, 2024

Business

Market correction rattles IPOs as stocks listed in 2021 trade 10-50% below their highs

Market correction rattles IPOs as stocks listed in 2021 trade 10-50% below their highs

Year 2021 turned out to be very strong for the primary market, which was supported by a strong secondary market environment, but the recent correction in the market, seen for several months now, has reduced sentiment because some registered stocks traded 10-50 percent lower than their highest .

Nifty50 corrected more than 11 percent of the record high of 18.604 (touching October 19) before the current recovery of 5 percent of the recent lowest position. This correction is guaranteed especially after a one-way run for more than 18 months creates expensive markets compared to global colleagues. Omicron’s fear and increasing expectations for the increase in interest rates in the US caused a reversal of market trends.

That year saw 65 IPOs launched and 62 of them have so far been listed on the stock exchange. Many of them created a refund of multibagger on their journey this year, but everything is now trading under their highest.

Small Finance Bank Suryoday and Cartrade Tech are the biggest losers, falling around 50 percent each from their highest. In addition, both stocks also fell by around 50 percent of the price of the problem.

Defense and outer Space Technology also lost more than 45 percent of the highest point, but remains a multibagger up among IPOs, providing a return of 292 percent of the problem price. Indigo Hole, Windlas Biotech, Krsnaa diagnostics and cell handling waste Antony lose more than 40 percent of their highest profits.

Data shows that 33 shares fell more than 20 percent of their highest. Nureca and Laxmi Organic Industry, the second largest and third multibragger among IPOs, fell 39 percent and 37 percent of their highest. However, their profits are 253 percent and 205 percent, compared to problem prices.

Sigachi Industries and Barbeque-Nation Hospitality also corrected more than 35 percent of the highest, but they still rose 144 percent of the problem prices.

Apart from the concerns of omicron and the tightening of the central bank, high assessment or run-up in front of the fundamentals is the main cause behind the correction not only in the market but also in stock.

“We need to realize that IPO investment is at risk, and most companies go public in high assessment. In the market today, where there has been a correction of 10 percent in the market and uncertainty around the market prospects because Omicron and rates are increasing throughout the world, risk assets suffering throughout the market, and the IPO is one of the asset classes, “said Sonam Srivastava. , Wright Research founder.

Experts mostly believe companies have strong fundamentals and reach on reasonable assessments will surely see strong recovery going forward, while others can remain around or below the price.

In general, companies have a strong growth trace record and the potential is always on the buyer’s radar.

“We honestly waiting for a market rebound to get a clearer picture. We expect a more interesting company from the assessment and growth perspective to rebound from Drawdown quickly, while others who don’t look too interesting will remain fluctuating. Nazara Technologies, Paras Defense , Zomato, Nykaa are some of the desired names in this list that investors can be watched, “said Sonam Srivastava.

On the other hand, Anupam Rasayan India, Medplus Health Services, Krishna Institute of Medical Science, Anand Rathi Wealth, Brookfield India Reit, Metro Brands, Mtar Technologies, Signgain Travel Technologies, CE Info Systems (Mapmyindia), Clean Science & Technology, and The Rolex ring is the performance of the IPO registered so far in 2021, because they fell only 1-10 percent of their highs but all, except the Metro & Raysgain brand, traded higher than their prices.

Leave a Reply

Your email address will not be published. Required fields are marked *